Table 2.

Comparison of clinical characteristics between AA patients according to the STAT3 mutation status

Variable	AAs with STAT3 mutation, n = 16	AAs without STAT3 mutation, n = 124	P
Age, years (median, range)	48	41	.8
Sex, %
Male	66	52	.3
Female	34	48
Moderate severity, %	29	21	.3
Presence of PNH clone, %	54	38	.2
HLA-DR15, %	75	44	.02
Any response to first line, %	81	61	.1